Nanomedicine: Market Research Report

Date: July 22, 2009
Pages: 698
US$ 3,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

Nanomedicine: Market Research Report
This report analyzes the Global Market for Nanomedicine in Millions of US$ by the following Application Areas: Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials, and Others.

Annual forecasts are provided for the period of 2006 through 2015.

The report profiles 263 companies including many key and niche players worldwide such as Abraxis BioScience, Inc., Acusphere, Inc., Advion Biosciences, Inc., Agilent Technologies, Inc., AMAG Pharmaceuticals, Inc., Amgen, Inc., Arrowhead Research Corporation, Calando Pharmaceuticals, Inc., Nanotope, Inc., Tego BioSciences Corporation, BioForce Nanosciences, Inc., BioSante Pharmaceuticals, Inc., Crucell N.V., Elan Corporation Plc, Elan Drug Technologies, Ensysce Biosciences, Inc., Enzon Pharmaceuticals, Inc., eSpin Technologies, Inc., Flamel Technologies S.A., Johnson & Johnson, Life Technologies Corporation, Merck & Co., Inc., Nanobiotix, NanoCarrier Co., Ltd., Nanospectra Biosciences, Inc, Nanosphere, Inc., Nanosys, Inc., Nektar Therapeutics, Novavax, Inc., Oxonica Plc, Par Pharmaceutical Companies, Inc, pSivida Limited, Starpharma Holdings Limited, Dendritic Nanotechnologies, Inc., Starpharma Pty.Ltd., and Wyeth Pharmaceuticals, Inc.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

Study Reliability and Reporting Limitations
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Drug Delivery
In Vitro Diagnostics
In Vivo Imaging



Current and Future Analysis
Industry Drivers
Industry Challenges
Developing World Ready to Adopt Nanomedicine in a Major Way
Nanotechnology Based Medical Products

Table 1. Global Nanomedicine Market (2007): Percentage Breakdown of Number of Nano-Based Products by Application Area - Drug Delivery, Biomaterials, In Vivo Imaging, and Others (includes corresponding Graph/Chart)

Nanotechnology Based Drug Delivery Products

Table 2. Global Nanomedicine Market (2007): Percentage Breakdown of Number of Nano-Based Drug Delivery Products by Category - Liposomes, Nanocristals, Virosomes, and Others (includes corresponding Graph/Chart)

Nanomedicine Patent Filings

Table 3. Global Nanomedicine Market (1993-2003): Percentage Breakdown of Nanomedicine Patents by Application Area – Drug Delivery, In Vitro Diagnostics, Imaging, Biomaterials, and Others (includes corresponding Graph/Chart)
Table 4. Global Nanomedicine Market (1993-2003): Percentage Breakdown of Patents by Country - US, Germany, Japan, and Others (includes corresponding Graph/Chart)


Nanomedicine - The Future Direction
Transforming Healthcare Sector Generating Demand for Nanomedicine
Nanobiotechnology – A Promising Area
High Demand for Tiny Healthcare Devices
Research in Nanomedicine Continues to Surge
Nanotechnology in Healthcare to Sustain R&D Funding
Nanomedicine Clinical Pipeline to Sustain the Momentum
Nanotechnology Gaining Ground in Fast Growing Drug Delivery Market
Nanotechnology – Generating More Enthusiasm Among Entrants
Demand for Supplies and Devices to Grow Rapidly
Nanomedicine Needs Analysis of Ethical Implications
Nanotechnology-based Drug Delivery Market on an Upbeat
Nanotechnology Opens Up New Frontiers in Drug Discovery
Nanotechnology Raises Hope for Tuberculosis Treatment
Demand for Nano-Based Medical Products to Rise Significantly
Medical Nanorobotics to Raise the Standards
Nanomedicine – A Useful Element in Surgical Procedures
Nano-based Diagnosis and Medical Imaging Helps Treatment of Critical Diseases
More Efficient Nanoparticles Could be Made Possible by Modeling Software
Major Issues Daunting Nanomedicine Sector


Nanomedicine - A Primer
Radio-Controlled Biomolecules
Quantum Dots
Ceramic Nanoparticles
Solid Lipid Nanoparticles
Liquid Crystals
Polymeric Nanoparticles
Molecularly Imprinted Polymers


Drug Delivery
Targeted Nanodrug Delivery & Release
Active and Passive Targeting Mechanisms in Drug Delivery
Sustained and Pulsatile Release Mechanisms in Drug Delivery
In Vitro Diagnostics
In Vivo Imaging
Drugs and Therapy
Active Medical Implants
Key Applications in Cancer Therapy
Advanced Imaging, Early-Stage Detection, and Targeting
In-vivo Imaging
Effective Tracking of Process Efficiency
Advancing Bioinformatics and Proteomics Research
Carbon Nanotubes in Cancer Treatment
Regenerative Medicine
Futuristic Applications
Bio-molecular Motors
Genetic and Tissue Engineering
External Tissue Products
Internal Tissue Implants
Dental and Bone Replacement
Protein and Gene Analysis
Nanorobot Therapeutics
Lab-on-a-Chip Techniques
Medical Diagnostic Sensors
Nano Medical Devices – From Surgical Tools to Contact Lenses
Nanoengineered Prosthetics
Nanotubes – Potential Drug Delivery Vehicles


Building Blocks of Nanotechnology Used, Components and Final End-Use Products
Global Nanotechnology Market

Table 5. Global Nanotechnology Market (2008 & 2009): Percentage Breakdown of Revenues by End-Use Segments – Chemicals, Automotive, Aerospace & Defense, Semi-Conductors & Electronics, Nanomedicine and Others (includes corresponding Graph/Chart)

Commercial Applications at an Embryonic Stage
Recent Commercial Applications of Nanotechnology
Nanotech Players – Germany Tops Europe While China Leads Asia-Pacific

Table 6. Nanotech Companies in Europe (2007): Number of Players in Major Regional Markets - Germany, United Kingdom, Switzerland, France, and Sweden (includes corresponding Graph/Chart)
Table 7. Nanotech Companies in Asia-Pacific (2007): Number of Players in Major Regional Markets - China, South Korea, Japan, Australia, and Taiwan (includes corresponding Graph/Chart)

Nanotech Funding by Regional Governments

Table 8. Nanotech Funding by Regional Governments (2008): Leading National Markets Ranked by Funding in US$ Million for United States, Japan, Russia, Germany and China (includes corresponding Graph/Chart)


German Scientists Develop Nanoparticle-Driven Gene Transfer Method
Oxford Sees Progress in its Novel DNA Sequencing Technology Project
Philips Releases First 3D Imaging Findings
Researchers in University of Pennsylvania Invent Novel Carbon Nanopipette
UCLA Scientists Develop Localized and Controlled Drug Delivery Method
Minerva Makes New Discovery in Cancer Treatment
NanoBio Releases Positive Data with NB-002
NanoBio Receives Positive Pre-Clinical Results with Intranasal Influenza Vaccine
Abraxis Announces Interim Results of Abraxane® for Metastatic Breast Cancer
Abraxis Reveals Positive Data with Abraxane® and Gemzar®
BioDelivery Commences Clinical Study with Bioral® Amphotericin B
NanoCarrier Develops Protein Nanoencapsulation Technology
Flamel Releases Positive Preliminary Data from FT-105 Phase I Study
Abraxis Releases Positive Pre-Clinical Data with nab™ Technology Platform and SPARC Expression in Cancer Treatment
American Scientists Develop Unique Nano-Based Drug Delivery System
Researchers at University of Queensland Focus to Develop Novel Nano-based Diagnostics for Cancer Detection
Indian Researchers Synthesize Polymeric Nanocurcumin for Cancer Therapy
Researchers Mull on Using Nanoparticles to Develop Anti-Tumor Vaccines
Nanomedicine Creates New Avenues for Regeneration of Nerve Cells
University of Illinois Develop Enhanced Biomimetic Membranes
Johns Hopkins Faculty develop Nanoparticle-Embedded Microcapsules
Max Planck Research Team Develops Gold Nanoparticles
Nanotechnology based Panacea for Facial Wrinkles


Starpharma Holdings Releases the NanoJuice™ Transfection Kit
Telomolecular Introduces Nano-Based Aging Solution
CytoViva® Unveils Advanced Nanotechnology Research Tool
eBioscience Introduces eFluor™ Brand
eBioscience Launches eFluor™ Nanocrystals
BioForce Nanosciences Unveils Surface Patterning Service
Eastman Kodak Unveils KODAK X-SIGHT Imaging Agents
Biomet Launches NanoTite Dental Implant
Deerac Introduces Equator HTS/2 Liquid Handling Solution
IMEC Develops Functionalized Magnetic Nanoparticles
Ivoclar Vivadent Introduces New Version of Tetric Flow
Calando to Begin Human Clinical Trials for siRNA-based Therapeutic Drug for Cancer
Dabur Pharma Launches Nano-Based Drug Delivery System


APR Acquires New Drug Delivery Platform
Merck Inks Merger Agreement with Schering-Plough
Nanobiotix to Collaborate with SonoDrugs Project Consortium
Liquidia and Abbott to Jointly Develop siRNA Therapeutics
Pro-Tect Acquires Medivices’ Nanotechnology Method
APR to Create Dedicated Nanotechnology Unit
Agilent Takes Over Nano Instruments
Veridex Acquires Immunicon
Thermo Fisher Takes Over nAscent
Labcyte and Deerac Fluidics Combine Operations
Invitrogen and Applied Biosystems Merge to Form Life Technologies
Insert Therapeutics Merges with Calando Pharmaceuticals
Capsulution Nanoscience and NanoDel Technologies Merge
BioForce Forms Collaboration with UAlbany NanoCollege
Advion and Bruker Daltonik Enter into Joint Marketing Agreement
Midatech Group Inks Agreement with MonoSol Rx
Advion Signs Co-Marketing Agreement with Agilent Technologies
Abraxis Inks Deal to Re-Acquire US Rights to Abraxane
NanoKTN and Bio Nano to Develop Nanomedicine
Evolved Machines Inks License Contract with Nanosys
Abraxis Bags European Commission Approval to Market Abraxane
Nanogen Eyes European Molecular Diagnostics Market
Abraxis Receives Approval for Marketing ABRAXANE in Korea and China
BioForce Receives MIT Validation for Nano eNabler Molecular Printer
Oxonica and Becton, Dickinson and Co. Sign Strategic Deal
Nanogen Sells Royalties to DRI Capital
Nanogen Signs Deal with Thermo Fisher
Midatech Establishes New Nanotechnology Subsidiary
Nanogen and HX Diagnostics Extend Collaboration
CytImmune Joins Hands with University of Maryland
Abraxis Inks Licensing Deal with Japan’s Taiho
Abraxis Files Marketing Application for Abraxane in Japan
BioForce Secures State Funding for ViriChip™
Capsulution and Advanced Materials Ink Patent License Deal
Midatech Bags US Grant on Patent Application
Nanobiotix Wins European Patent for Activable Particles
Nanotherapeutics Submits IND Application for NanoDOX ™ Hydrogel
Nanobiotix to Focus on Development of Diagnostics for Tropical Diseases
Ceres to Develop Novel Nanotechnology Products
Batist to Commence Production of Nanotechnology- Based Bandage
Unidym Creates Spin-Off Unit
Avanti Creates Dedicated Targeted Drug Delivery Company
Hill-Rom Chooses Anti-Microbial Technology of NanoHorizons
Advion Acquires NanoTek
Pioneer Surgical Acquires Angstrom Medica
Arrowhead Acquires C Sixty
Veritek Completes Acquisition of Omni-Lite E-Form
Wyeth Extends Collaboration with Ablynx
Starpharma Inks Agreement with Stiefel
Nanosys Signs Collaboration Deal with Bruker Daltonics
Abraxis Selects Green Cross to Commercialize Abraxane in Korea
Abraxis Signs Deal to Partner California NanoSystems Institute
BioForce Nanosciences Inflates Clientele Base for Nano eNabler™ System
Xidex Bags Contract to Make Carbon Nanotube Sources for Electron Microscopes
Novartis Extends Deal with Ablynx
BioSante Inks License Agreement with Medical Aesthetics
NanoImaging Launches Imaging Services Unit
Midatech Inaugurates cGMP Standard Nanoparticles Production Facility
Abraxis Announces Dedicated Proprietary Biotechnology Business
Eksigent Signs Distribution Deal in Brazil
NanoVic Establishes Two Nano-bio Companies
Veeco Signs Collaboration Deal with Leica
NanoViricides Inks CRADA with USDoD Agency
Rexahn Wins Maryland Industrial Partnerships Funding
Azaya Therapeutics Gains Patent for Nanotech-Based Cancer Treatment Platform
Flamel Inks Deal with Wyeth Pharmaceuticals
Flamel Signs Deal with Merck Serono
NanoChip® 400 Platform of Nanogen Now a GSA Schedule Product
Nanogen Bags Canadian Funding for Veterinary and Bio-Terror Diagnostics Development Project
Nanogen Signs Deal in Australia for Schizophrenia Markers
Wyeth Wins FDA Approval for New Labeling for Rapamune
Arrowhead Infuses Capital into Tego
GSK Extends Collaboration with Exelixis
Oncologix Collaborates with Dendritic Nanotechnologies to Redesign its Oncosphere Product
Abraxis Signs Licensing Contract in India
Abraxis Receives Australian TGA’s Acceptance to Review Marketing Application for Abraxane®
Nanotherapeutics and National Cancer Institute Sign CRADA
Relisys and Cinvention Extend Licensing Agreement
Lumera Extends Collaboration Pact with Medical University of South Carolina


Abraxis BioScience, Inc. (US)
Acusphere, Inc. (US)
Advion Biosciences, Inc. (US)
Agilent Technologies, Inc. (US)
AMAG Pharmaceuticals, Inc. (US)
Amgen, Inc. (US)
Arrowhead Research Corporation (US)
Calando Pharmaceuticals, Inc. (US)
Nanotope, Inc. (US)
Tego BioSciences Corporation (US)
BioForce Nanosciences, Inc. (US)
BioSante Pharmaceuticals, Inc. (US)
Crucell N.V. (The Netherlands)
Elan Corporation Plc (Ireland)
Elan Drug Technologies (Ireland)
Ensysce Biosciences, Inc. (US)
Enzon Pharmaceuticals, Inc. (US)
eSpin Technologies, Inc. (US)
Flamel Technologies S.A. (France)
Johnson & Johnson (US)
Life Technologies Corporation (US)
Merck & Co., Inc. (US)
Nanobiotix (France)
NanoCarrier Co., Ltd. (Japan)
Nanospectra Biosciences, Inc. (US)
Nanosphere, Inc. (US)
Nanosys, Inc. (US)
Nektar Therapeutics (US)
Novavax, Inc. (US)
Oxonica Plc (UK)
Par Pharmaceutical Companies, Inc. (US)
pSivida Limited (Australia)
Starpharma Holdings Limited (Australia)
Dendritic Nanotechnologies, Inc. (US)
Starpharma Pty. Ltd. (Australia)
Wyeth Pharmaceuticals, Inc. (US)


Table 9. World Recent Past, Current & Future Analysis for Nanomedicine Market by Application Area – Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials and Other Applications Independently Analyzed with Annual Revenues in US$ Million for the Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 10. World 10-Year Perspective for Nanomedicine Market by Application Area – Percentage Breakdown of Revenues for Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials and Other Applications for the Years 2006, 2009 and 2015 (includes corresponding Graph/Chart)


Total Companies Profiled: 263 (including Divisions/Subsidiaries - 269)
The United States
The United Kingdom
Rest of Europe19
Asia-Pacific (Excluding Japan)
Middle East8
Skip to top

Rheumatoid Arthritis Therapeutics: Market Research Report US$ 3,950.00 Feb, 2010 · 824 pages
Natural and Cultured Pearls: Market Research Report US$ 4,500.00 Jan, 2015 · 105 pages
Data Processing Services: Market Research Report US$ 1,995.00 Jan, 2012 · 111 pages
Fabric Softeners and Conditioners: Market Research Report US$ 4,500.00 Jan, 2018 · 225 pages
Whey Proteins: Market Research Report US$ 4,500.00 Jun, 2010 · 177 pages

Ask Your Question

Nanomedicine: Market Research Report
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: